Stevioside Inhibits Lipopolysaccharide-Induced Epithelial-to-mesenchymal Transition of NRK-52E Cells by PPARγ Activation.
Wei Shen,Hui Huang,Jie Xue,Mei-Lin Xie
DOI: https://doi.org/10.1080/08923973.2022.2039935
IF: 3.712
2022-01-01
Immunopharmacology and Immunotoxicology
Abstract:Background: Stevioside is a natural diterpenoid compound that possesses anti-inflammatory, immunomodulatory, anti-diabetic, anti-hypertensive, and renal protective effects, but its effect on lipopolysaccharide (LPS)-induced epithelial-to-mesenchymal transition (EMT) of renal tubular epithelial cells, an important immune pathological mechanism of renal fibrosis, remains unknown. This study employed the renal proximal tubular cells NRK-52E to investigate the effect of stevioside. Methods: The LPS-stimulated renal NRK-52E cells were treated with 50, 100, or 200 mu M stevioside in the presence or absence of peroxisome proliferator-activated receptor gamma (PPAR gamma) antagonist GW9662, the expression levels of intracellular E-cadherin, vimentin, alpha-smooth muscle actin (alpha-SMA), PPAR gamma, nuclear factor kappa B (NF-kappa B) p65, transforming growth factor-beta 1 (TGF-beta 1), signal transducer and activator of transcription 3 (STAT3), p-STAT3, Smad2/3, and p-Smad2/3 proteins were detected by Western blot analysis. Results: In LPS-stimulated NRK-52E cells, stevioside treatment could reverse the expressions of EMT-related E-cadherin, vimentin, and alpha-SMA proteins, increase the expression of PPAR gamma protein, and decrease the expressions of NF-kappa B p65, TGF-beta 1, p-STAT3, Smad2/3, and p-Smad2/3 proteins, especially in the 200 mu M stevioside-treated group. However, these beneficial effects of stevioside were attenuated or canceled by pretreatment with PPAR gamma antagonist GW9662. Conclusions: Stevioside can inhibit the LPS-induced EMT via the reductions of NF-kappa B, TGF-beta 1, Smad2/3, p-Smad2/3, and p-STAT3 protein expressions by PPAR gamma activation in NRK-52E cells, which may provide a pharmacological basis for the potential application of stevioside in the prevention and treatment of renal fibrosis.